Pharma Equity A/S : 2024 Q1 Consolidated Interim Report
Consolidated interim report for the 3 month-period ended 31 March 2024 Pharma Equity Group A/S Slotsmarken 18, 2.,...
Source: marketscreener.com
Stay updated with breaking news from Kaas Sels. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Consolidated interim report for the 3 month-period ended 31 March 2024 Pharma Equity Group A/S Slotsmarken 18, 2.,...
The Board of Director's decision to issue convertible loans 16 May 2024Company Announcement no. 18 The Board of Directors of Pharma Equity Group...
The Board of Director's decision to issue convertible loans ...
5 April 2024 Company Announcement No. 11 Pharma Equity Group’s subsidiary, Reponex Pharmaceuticals A/S, reports highly positive final results from the phase-2 clinical trial of the company’s...